Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Decoding the complex nexus: the mechanistic interplay of hyperhomocysteinemia in brain aging and neurological disorders.

Biogerontology·2026
Same author

Targeting excitatory/inhibitory neurotransmission by wogonin: integrated <i>In Silico</i> and <i>In Vivo</i> evidence in Parkinson's disease model.

Neurodegenerative disease management·2026
Same author

Determinants of husbands' involvement in family planning: Evidence from a community-based cross-sectional study in Uttar Pradesh, India.

PloS one·2026
Same author

Pterostilbene Orchestrates Synaptic Remodeling and Mitochondrial Functional Reconstitution to Attenuate Ischemic Vascular Dementia.

Neuromolecular medicine·2026
Same author

Wogonin-mediated modulation of cellular signaling pathways: Mechanistic insights into neuroprotection.

Molecular biology reports·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Vishal Shivaji Patil1, Bhaskar Jyoti Dutta1, Sanjiv Singh1

  • 1National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

一种新的pterostilbene (PTE) 纳米乳液配方有效地改善了血管痴呆症 (VaD) 模型中的认知功能. 这种输送系统增强了大脑的生物可用性,为VaD治疗提供了一个有前途的策略.

科学领域:

  • 神经科学是一个神经科学.
  • 药理学 药理学是指药理学的学科.
  • 生物技术是生物技术.

背景情况:

  • 血管性痴呆 (VaD) 是认知能力下降的主要原因,仅次于阿尔茨海默病.
  • 固醇 (PTE) 由于其抗氧化和抗炎性质,显示出对VaD的治疗潜力.
  • 由于PTE的溶解性和生物利用性较差,限制了其临床使用.

研究的目的:

  • 开发一种新型的pterostilbene (PTE) 纳米乳液配方,用于增强大脑输送.
  • 为了克服PTE水溶性差和生物可用性低的局限性.
  • 为了评估纳米乳液在患有血管痴呆症的老鼠模型中的疗效.

主要方法:

  • 一种带有PTE的纳米乳液 (PNE) 的配方,并将其转化为热敏粘粘性纳米乳液 (PNEG),用于鼻腔输送.
  • 对PNEG的物理化学性质,粘膜粘合和药物释放的表征.
  • 在体外细胞毒性和细胞吸收研究中,随后在老鼠模型中进行体内疗效评估,以双边常见动脉阻塞 (BCCAO) 诱导的VaD.

主要成果:

  • PNEG表现出有利的物理化学特性,包括最佳颗粒大小和强大的粘膜粘合.
  • 在体内研究表明,在接受PNE和PNEG治疗的VaD大鼠中,认知能力显著改善.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451
  • 通过调节SIRT1/Nrf2/HO-1通路,PNEG有效降低了氧化应激,细胞亡和神经炎症.
  • 结论:

    • 聚乙烯纳米乳液 (PNEG) 是血管痴呆症的一个有前途的治疗策略.
    • 这种配方增强了大脑的生物可用性,解决了传统PTE输送的局限性.
    • 通过有针对性的神经保护和认知维护,PNEG提供了改善VaD管理的潜力.